Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Radko Komers

Division of Nephrology and Hypertension

Department of Medicine

Oregon Health and Science University

Portland

USA

[email]@ohsu.edu

Name/email consistency: high

[Claim this account]

Affiliations

Division of Nephrology and Hypertension, Department of Medicine, Oregon Health and Science University, Portland, USA. 2000 - 2012
Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. 1999 - 2000

References

Enhanced phosphorylation of Na(+)-Cl- co-transporter in experimental metabolic syndrome: role of insulin. Komers, R., Rogers, S., Oyama, T.T., Xu, B., Yang, C.L., McCormick, J., Ellison, D.H. Clin. Sci. (2012) [Pubmed]
A polymorphism in the cyclooxygenase 2 gene in type 1 diabetic patients with nephropathy. Hubáček, J.A., Pelikánová, T., Lánská, V., Komers, R. Physiol. Res (2011) [Pubmed]
Effects of systemic inhibition of Rho kinase on blood pressure and renal haemodynamics in diabetic rats. Komers, R., Oyama, T.T., Beard, D.R., Anderson, S. Br. J. Pharmacol. (2011) [Pubmed]
Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure. Komers, R., Oyama, T.T., Beard, D.R., Tikellis, C., Xu, B., Lotspeich, D.F., Anderson, S. Kidney Int. (2011) [Pubmed]
What is the role of renin inhibition in the treatment of diabetic kidney disease? Komers, R. Curr. Diab. Rep. (2009) [Pubmed]
Renal p38 MAP kinase activity in experimental diabetes. Komers, R., Lindsley, J.N., Oyama, T.T., Cohen, D.M., Anderson, S. Lab. Invest. (2007) [Pubmed]
Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats. Komers, R., Schutzer, W., Xue, H., Oyama, T.T., Lindsley, J.N., Anderson, S. Transl. Res (2007) [Pubmed]
Cyclo-oxygenase-2 inhibition attenuates the progression of nephropathy in uninephrectomized diabetic rats. Komers, R., Lindsley, J.N., Oyama, T.T., Anderson, S. Clin. Exp. Pharmacol. Physiol. (2007) [Pubmed]
Altered endothelial nitric oxide synthase targeting and conformation and caveolin-1 expression in the diabetic kidney. Komers, R., Schutzer, W.E., Reed, J.F., Lindsley, J.N., Oyama, T.T., Buck, D.C., Mader, S.L., Anderson, S. Diabetes (2006) [Pubmed]
Effect of ACE inhibition and angiotensin AT1 receptor blockade on renal and blood pressure response to L-arginine in humans. Komers, R., Komersova, K., Kazdova, L., Ruzickova, J., Pelikanova, T. J. Hypertens. (2000) [Pubmed]
Therapeutic potential of ACE inhibitors for the treatment of hypertension in Type 2 diabetes. Komers, R., Komersova, K. Expert. Opin. Investig. Drugs (2000) [Pubmed]
Effect of hyperinsulinaemia on renal function and nitrate/nitrite excretion in healthy subjects. Komers, R., Pelikanová, T., Kazdová, L. Clin. Exp. Pharmacol. Physiol. (1999) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.